Rutherford Cancer Centres

Rutherford Cancer Centres was a UK private oncology care network that operated advanced cancer treatment and diagnostic centres under the Rutherford Health group. The network offered proton beam therapy, radiotherapy, chemotherapy, immunotherapy delivery, diagnostic imaging, and supportive cancer care services across multiple UK sites. The requested name most closely matches the trading name of the centre network rather than a drug-development biotech company; the underlying operating company was Rutherford Cancer Care, formerly The Rutherford Cancer Centres. The group entered liquidation in June 2022, and treatment and diagnostic services at the Northumbria, Liverpool, Reading, and Newport sites ceased. As a result, the business is no longer active as an operating cancer-care company.